Emboliner Embolic Protection System Cleared by FDA for TAVR

September 10, 2026—Emboline, Inc. announced that the FDA has granted 510(k) clearance for the Emboliner embolic protection system to capture and remove embolic material during transcatheter aortic valve replacement (TAVR).

MicroPort’s FireShield Coronary Covered Stent System Enters China’s NMPA Special Review Procedure

September 4, 2026—MicroPort Coronary, a medical device company based in Shanghai, China, announced that its FireShield coronary covered stent system has been included in China’s National Medical Products Administration (NMPA) special review procedures for innovative medical devices (known as the “Green Channel”).

Findings Presented for Caristo’s FAI-Score Biomarker and Other NC Cardiac CT Applications 

September 4, 2026—Caristo Diagnostics announced new research demonstrating that the company’s FAI-Score biomarker can unlock coronary inflammation assessment in noncontrast cardiac CT, identifying high risk even in patients with a zero coronary calcium score.

Vesalio’s enVast for Mechanical Thrombectomy in Large-Thrombus STEMI Studied in NATURE

September 3, 2026—Vesalio announced results from the NATURE trial of the company’s enVast coronary clot retriever.

Shockwave Medical to Rebrand as Johnson & Johnson MedTech

September 1, 2026—Shockwave Medical announced on the company’s LinkedIn page that it will be rebranded as Johnson & Johnson MedTech with Shockwave’s technologies to be known as “circulatory restoration solutions,” effective October 1, 2026.

TRUST Pivotal Study of Innova Laguna Thrombectomy System Completes Enrollment

September 1, 2026—Innova Vascular, Inc. announced the completion of patient enrollment in the TRUST pivotal investigational device exemption clinical study, which is evaluating the safety and effectiveness of the company’s Laguna thrombectomy system for the treatment of pulmonary embolism (PE).

Philips and Imricor Launch Cardiac Interventional MR Lab Solution 

August 28, 2026—Royal Philips and Imricor Medical Systems announced the launch of an interventional MR (iMR) lab solution that combines Philips’ 1.5T MRI platform and Imricor’s portfolio of iMR systems and consumables.

Abbott’s Amulet 360 LAA Occluder Receives CE Mark Approval

August 28, 2026—Abbott announced it has received CE Mark approval for the Amulet 360 left atrial appendage (LAA) occluder, a next-generation device designed to reduce risk of stroke in patients with nonvalvular atrial fibrillation (AFib).